🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Radiotherapy Side Effect

Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC) NCT07761910Phase 21 site📍 Indianapolis Indiana University · Tests: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz Patient Experience Data in Radiation Oncology NCT05224297n/a1 site📍 Vienna Medical University of Vienna · Tests: external beam photon therapy Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care NCT03882580n/a3 sites📍 Paris📍 Paris📍 Paris Groupe Hospitalier Pitie-Salpetriere · Tests: Anti-Cancer Agents Evaluation of Technological Innovation in Radiotherapy NCT03378856n/a9 sites📍 Kelowna📍 Vancouver📍 London Centre hospitalier de l'Université de Montréal (CHUM) Cardiovascular Complications in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. NCT07157670n/a1 site📍 Paris Assistance Publique - Hôpitaux de Paris Proton Therapy for Locally Advanced Cervical Cancer NCT06462378Phase 21 site📍 Copenhagen University of Aarhus · Tests: Proton therapy Microbiome Determinants of Adverse Effects of Stereotactic Radiosurgery NCT07767981n/a1 site📍 Chicago University of Chicago The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity NCT06214195Phase 31 site📍 Hangzhou Zhejiang Cancer Hospital · Tests: Shengmai San (ingredients include ginseng, Ophiopogon japonicus, and Schisandra chinensis) Gene and Molecular Pathways of Ozone Treatment Response in Gynecological Tumor Patients With Chronic Pelvic Pain Secondary to Cancer Treatment NCT06816095n/a1 site📍 Las Palmas Bernardino Clavo, MD, PhD A Multicenter Phase II Study of Stereotactic Radiotherapy for Centrally Located Lung Tumors (STRICT-LUNG STUDY) and Ultra-centrally Located Lung Tumors (STAR-LUNG STUDY). NCT05354596NA6 sites📍 Aalborg📍 Aarhus📍 Copenhagen Copenhagen University Hospital, Rigshospitalet · Tests: STRICT LUNG, STAR LUNG RAdiotherapy With FDG-PET Guided Dose-PAINTing Compared With Standard Radiotherapy for Primary Head and Neck Cancer-3 NCT06297902NA3 sites📍 Bergen📍 Oslo📍 Trondheim Oslo University Hospital · Tests: Dose painting The STOP-MED CTRCD Trial NCT06183437Phase 414 sites📍 Los Angeles📍 Boston📍 Melbourne Dinesh Thavendiranathan · Tests: Stopping Heart Failure Medication(s) Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. NCT06758830Phase 2, Phase 31 site📍 Vilnius National Cancer Center Affiliate of Vilnius University Hosp… · Tests: Radiation Therapy, Chemoradiotherapy, Consolidation Chemotherapy, Surgery, Part two Preoperative Ultra-hypofractionated Radiotherapy Followed by Surgery for Retroperitoneal Sarcoma (FUSION-01) NCT05224934NA1 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: ultra-hypofractionated radiotherapy AI as an Aid for Weekly Symptom Intake in Radiotherapy NCT06525181NA1 site📍 Rio de Janeiro jaide · Tests: Generative Artificial Intelligence, Standard weekly symptom intake ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies NCT07191730n/a1 site📍 Caen University Hospital, Caen Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes NCT06321653n/a1 site📍 Milan European Institute of Oncology · Tests: Hypofractionated radiotherapy scheme Breast Cancer Long-term Outcomes on Cardiac Functioning: a Longitudinal Study NCT05851053n/a1 site📍 Groningen University Medical Center Groningen · Tests: Echocardiography Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor NCT06311955Phase 21 site📍 Shanghai Jian Chen · Tests: Carbon ion radiotherapy, combined with platinum-based regimen Attribution of Toxicities Due to Radiotherapy and Immuno-Biological Therapies NCT04115267n/a1 site📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Radiotherapy Weight Management in Obese Cancer Patients During Curative Active Treatment NCT07058207NA1 site📍 L'Hospitalet de Llobregat Institut d'Investigació Biomèdica de Bellvitge · Tests: Multimodal weight management program Carbon Ion Radiotherapy for Locally Advanced Lung Cancer in Elderly Patients NCT06311981Phase 21 site📍 Shanghai Jian Chen · Tests: carbon ion radiotherapy, targeted therapy, single regimen chemotherapy in sequence with radiotherapy Cardiovascular Health in Adult Patients With Cancer Exposed to Cardiotoxic Therapies NCT06664528n/a1 site📍 Rome Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Tests: ECHOCARDIOGRAPHY, ELECTROCARDIOGRAPHY (ECG), LABORATORY TESTS NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity NCT06340516NA1 site📍 Gothenburg Vastra Gotaland Region · Tests: Plasma NT-proBNP Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer NCT06929468n/a1 site📍 Nuremberg Simon Jäger Curatively Intended Thoracic Reirradiation NCT06950073n/a1 site📍 Aarhus University of Aarhus · Tests: Radiotherapy Treatment of Radiation and Cisplatin Induced Toxicities with Tempol NCT03480971Phase 29 sites📍 La Jolla📍 Merced📍 San Francisco Matrix Biomed, Inc. · Tests: Tempol, Placebo Solution Lithium Treatment to Prevent Cognitive Impairment After Brain Radiotherapy NCT06051240Phase 22 sites📍 Solna📍 Stockholm Region Stockholm · Tests: Lithium, Placebo The HIMALAYAS Trial and Lifestyle Changes in Pediatric, Adolescent and Young Adult Cancer Survivors Study: A Multicentre Randomized Controlled Trial NCT05023785NA1 site📍 Toronto University Health Network, Toronto · Tests: Cardio-oncology Rehabilitation (CORE) Adaptive RadioTherapy for OroPharynx Cancer NCT04901234Phase 22 sites📍 Melbourne📍 Montreal Centre hospitalier de l'Université de Montréal (CHUM) · Tests: Standard radiotherapy +/- chemotherapy, Experimental radiotherapy +/- chemotherapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy